Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity

Autor: Gj, Grover, Alonzo Aj, D., Keith Garlid, Bajgar R, Nj, Lodge, Pg, Sleph, Rb, Darbenzio, Ta, Hess, Ma, Smith, Paucek P, Ks, Atwal

Publikováno v: Europe PubMed Central

Previous work described ATP-sensitive K(+) channel (K(ATP)) openers (e.g., BMS-180448), which retain the cardioprotective activity of agents such as cromakalim while being significantly less potent as vasodilators. In this study, we describe the phar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::28d1728cd9b141566b2813444eaa1c4c
https://pubmed.ncbi.nlm.nih.gov/11356945

An OpenStreetMap derived building classification dataset for the United States.

Autor: F de Arruda H; Geography and Geoinformation Science, College of Science, George Mason University, 4400 University Dr., Fairfax, 22030, VA, USA. h.f.arruda@gmail.com., Reia SM; Geography and Geoinformation Science, College of Science, George Mason University, 4400 University Dr., Fairfax, 22030, VA, USA., Ruan S; Geography and Geoinformation Science, College of Science, George Mason University, 4400 University Dr., Fairfax, 22030, VA, USA., Atwal KS; Geography and Geoinformation Science, College of Science, George Mason University, 4400 University Dr., Fairfax, 22030, VA, USA., Kavak H; Center for Social Complexity, College of Science, George Mason University, 4400 University Dr., Fairfax, 22030, VA, USA., Anderson T; Geography and Geoinformation Science, College of Science, George Mason University, 4400 University Dr., Fairfax, 22030, VA, USA., Pfoser D; Geography and Geoinformation Science, College of Science, George Mason University, 4400 University Dr., Fairfax, 22030, VA, USA.

Publikováno v: Scientific data [Sci Data] 2024 Nov 09; Vol. 11 (1), pp. 1210. Date of Electronic Publication: 2024 Nov 09.

Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.

Autor: Shi Y; Research and Development, Bristol-Myers Squibb Company, PO Box 5400, Princeton, NJ 08543-5400, USA. Michael, O'Connor SP, Sitkoff D, Zhang J, Shi M, Bisaha SN, Wang Y, Li C, Ruan Z, Lawrence RM, Klei HE, Kish K, Liu EC, Seiler SM, Schweizer L, Steinbacher TE, Schumacher WA, Robl JA, Macor JE, Atwal KS, Stein PD

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Dec 15; Vol. 21 (24), pp. 7516-21. Date of Electronic Publication: 2011 Jun 28.

Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors.

Autor: Shi Y; Research and Development, Bristol-Myers Squibb Company, PO Box 5400, Princeton, NJ 08543-5400, USA. yan.shi@bms.com, Zhang J, Shi M, O'Connor SP, Bisaha SN, Li C, Sitkoff D, Pudzianowski AT, Chong S, Klei HE, Kish K, Yanchunas J Jr, Liu EC, Hartl KS, Seiler SM, Steinbacher TE, Schumacher WA, Atwal KS, Stein PD

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2009 Aug 01; Vol. 19 (15), pp. 4034-41. Date of Electronic Publication: 2009 Jun 13.

Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors.

Autor: Simpkins LM; Bristol-Myers Squibb Research and Development, PO Box 5400, Princeton, NJ 08543-5400, USA., Bolton S, Pi Z, Sutton JC, Kwon C, Zhao G, Magnin DR, Augeri DJ, Gungor T, Rotella DP, Sun Z, Liu Y, Slusarchyk WS, Marcinkeviciene J, Robertson JG, Wang A, Robl JA, Atwal KS, Zahler RL, Parker RA, Kirby MS, Hamann LG

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2007 Dec 01; Vol. 17 (23), pp. 6476-80. Date of Electronic Publication: 2007 Oct 01.